Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG) ; volume:8 ; number:1 ; day:16 ; month:5 ; year:2007 ; pages:1-18 ; date:12.2007
BMC immunology ; 8, Heft 1 (16.5.2007), 1-18, 12.2007
- Urheber
-
Saban, Marcia R.
Simpson, Cindy
Davis, Carole
Wallis, Gemma
Knowlton, Nicholas
Frank, Mark Barton
Centola, Michael
Gallucci, Randle M.
Saban, Ricardo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1471-2172-8-6
- URN
-
urn:nbn:de:101:1-2019090114134974581178
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Saban, Marcia R.
- Simpson, Cindy
- Davis, Carole
- Wallis, Gemma
- Knowlton, Nicholas
- Frank, Mark Barton
- Centola, Michael
- Gallucci, Randle M.
- Saban, Ricardo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-α
Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
Bacille Calmette-Guérin (BCG) spondylitis with adjacent mycotic aortic aneurysm after intravesical BCG therapy: a case report and literature review
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Untersuchungen zur Adhärenz von Bacillus Calmette Guérin (BCG) an permanenten Blasentumorzellinien
Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: abridged summary of the Cochrane Review
Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report
Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-α
Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
Bacille Calmette-Guérin (BCG) spondylitis with adjacent mycotic aortic aneurysm after intravesical BCG therapy: a case report and literature review
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Untersuchungen zur Adhärenz von Bacillus Calmette Guérin (BCG) an permanenten Blasentumorzellinien
Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: abridged summary of the Cochrane Review
Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report
Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-α
Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
Bacille Calmette-Guérin (BCG) spondylitis with adjacent mycotic aortic aneurysm after intravesical BCG therapy: a case report and literature review
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Bekämpfung der Tuberkulose: Schutzimpfung mit Bacillus Calmette-Guérin (BCG)
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Untersuchungen zur Adhärenz von Bacillus Calmette Guérin (BCG) an permanenten Blasentumorzellinien
Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: abridged summary of the Cochrane Review